Paper # 163
Association of IL28B Haplotypes with Chronic HCV Infection in HIV/HCV Co-infected Individuals
Julia di Iulio*1, P-Y Bochud1, M Rotger1, H Furrer2, F Negro3, A Telenti1, A Rauch2, and Swiss HIV and HCV Cohort Studies
1Univ Hosp Lausanne and Univ of Lausanne, Switzerland; 2Univ Hosp Bern and Univ of Bern, Switzerland; and 3Univ Hosp Geneva, Switzerland
Background: In a genome-wide association study
involving 347 individuals with spontaneous hepatitis C virus (HCV) clearance
and 1015 with chronic hepatitis C, we identified a single nucleotide
polymorphism (SNP), rs8099917, in the interferon lambda 3 (IL28B) locus
significantly associated with chronic (versus spontaneously cleared) hepatitis
C. To map the candidate causal variant or genetic region tagged by the risk
allele rs8099917, we re-sequenced the IL28B gene.
Methods: To maximize the likelihood of identifying
the causal region, we performed recombinant mapping on DNA from individuals
selected for having concordant (homozygous risk allele/chronic infection,
homozygous common allele/clearance) and discordant (homozygous risk
allele/clearance, homozygous common allele/chronic infection)
genotype-phenotype constellations. Fifteen individuals were selected per
constellation, except for the rare coupling risk allele/clearance, where only 2
individuals were available for analysis. All individuals were HIV-HCV
co-infected except 6 individuals with the common coupling risk allele/chronic
infection who were HCV mono-infected. We performed re-sequencing of the
promoter region (1491bp), exons and introns (1336bp) and the 3’UTR (1452bp).
Results: Re-sequencing of the IL28B locus
identified 21 SNP. Haplotype inference led to the identification of 2 main
haplotype families. The first family of haplotypes (Type I) included most
individuals (90%) with HCV clearance phenotype who carried the favorable
allele. The second family of haplotypes (Type II) carried most of the risk of
chronicity: it was harbored by 97% of individuals homozygous for the risk
allele and interestingly by 37% of “discordant” individuals that progressed to
chronic infection despite absence of the risk allele. Five SNP enriched in Type
II haplotypes were identified as candidates for being causal. These included 2
SNP in the promoter region (rs4803219 and rs28416813), an exonic SNP leading to
a non-synonymous amino acid substitution (rs8103142), and 2 SNPs in the 3’UTR
(rs4803217 and rs581930).
Conclusions: Re-sequencing of the IL28B locus
identified distinct haplotypes associated with chronic hepatitis C and several
specific SNP as candidates for being causal. This constitutes the first lead to
the causal allele and mechanism of action of IL28B for the natural
control of HCV infection.
|